Recently stock market analysts have updated their consensus ratings on shares of Alexza Pharmaceuticals, Inc. (ALXA). The latest broker reports which are currently outstanding on Monday 9th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.

Most recent broker ratings

03/27/2015 – Alexza Pharmaceuticals, Inc. had its “hold” rating reiterated by analysts at Roth Capital. They now have a USD 2.5 price target on the stock.

03/31/2014 – Alexza Pharmaceuticals, Inc. had its “positive” rating reiterated by analysts at Edison Group.

Alexza Pharmaceuticals, Inc. has a 50 day moving average of 0.56 and a 200 day moving average of 0.66. The stock’s market capitalization is 10.57M, it has a 52-week low of 0.22 and a 52-week high of 1.60.

The share price of the company (ALXA) was down -1.82% during the last trading session, with a high of 0.57 and the volume of Alexza Pharmaceuticals, Inc. shares traded was 21779.

View other investors thoughts on Alexza Pharmaceuticals, Inc. on our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.